Catalyst Pharmaceuticals, Inc.
CPRX
Clasificación en acciones
#4174
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables,... Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and neurological disorders. Among its key offerings is Firdapse, an amifampridine phosphate tablet formulation approved for managing Lambert-Eaton Myasthenic Syndrome (LEMS). Catalyst also provides Ruzurgi, a specific treatment option for pediatric patients diagnosed with LEMS. Beyond its existing products, Catalyst is actively investigating additional applications for Firdapse, including its potential use in treating MuSK antibody positive myasthenia gravis, spinal muscular atrophy type 3, and hereditary neuropathy with liability to pressure palsies. The company engages in various strategic collaborations, such as licensing agreements with BioMarin Pharmaceutical Inc., and a joint development and commercialization agreement with Endo Ventures Limited concerning a generic version of Sabril tablets. Previously known as Catalyst Pharmaceutical Partners, Inc., the company adopted its current name in May 2015.
Precio por acción
$31.49
Última sincronización: 2026-07-21
Capitalización bursátil
$3.85B
Cambio (1 día)
0.00%
Cambio (1 año)
49.88%
País
US
Comercio Catalyst Pharmaceuticals, Inc. (CPRX)
Categoría
Healthcare
Número de acciones en circulación de Catalyst Pharmaceuticals, Inc. (CPRX)
Número de acciones en circulación al March 2026: 122.25M
Según los últimos informes financieros y el precio de las acciones de Catalyst Pharmaceuticals, Inc., el número actual de acciones en circulación es 122.25M. Al final de December 2023, la empresa tenía 106.28M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Catalyst Pharmaceuticals, Inc. (CPRX) desde 2002 hasta 2026
Acciones en circulación al final de cada año
| Año | Acciones en circulación | Cambiar |
|---|---|---|
| 2026 (TTM) | 122.25M | 3.20% |
| 2024 | 118.46M | 11.46% |
| 2023 | 106.28M | 2.81% |
| 2022 | 103.37M | 0.00% |
| 2021 | 103.38M | -0.13% |
| 2020 | 103.51M | 0.55% |
| 2019 | 102.94M | 0.30% |
| 2018 | 102.63M | 19.62% |
| 2017 | 85.80M | 3.53% |
| 2016 | 82.88M | 2.49% |
| 2015 | 80.86M | 26.06% |
| 2014 | 64.14M | 41.12% |
| 2013 | 45.45M | 51.34% |
| 2012 | 30.03M | 38.22% |
| 2011 | 21.73M | 16.94% |
| 2010 | 18.58M | 23.32% |
| 2009 | 15.07M | 15.78% |
| 2008 | 13.01M | 3.89% |
| 2007 | 12.53M | 62.93% |
| 2006 | 7.69M | 23.90% |
| 2005 | 6.20M | 112.61% |
| 2004 | 2.92M | 0.00% |
| 2003 | 2.92M | 23.73% |
| 2002 | 2.36M | 0.00% |
Acciones en circulación de empresas similares o competidores
| Empresa | Acciones en circulación | Diferencia | País |
|---|---|---|---|
| 253.90M | 107.68% |
US
|
|
| 396.00M | 223.92% |
US
|
|
| 478.91M | 291.73% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -49.13% |
NL
|
